Nichi-Iko Pharmaceutical Co., Ltd. (NHKFF)
NHKFF Stock Price Chart
Explore Nichi-Iko Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze NHKFF price movements and trends.
NHKFF Company Profile
Discover essential business fundamentals and corporate details for Nichi-Iko Pharmaceutical Co., Ltd. (NHKFF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
26 May 2020
Employees
2.66K
Website
https://www.nichiiko.co.jpCEO
Shingo Iwamoto
Description
Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, and distributes various pharmaceutical products. It operates through two segments, Nichi-Iko Group and Sagent Group. The company primarily focuses on the production of generic drugs. It offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin ? antagonist, angiotensin ? antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products, as well as chemotherapeutic agents. The company also provides treatments for circulatory, digestive, respiratory, nervous system, allergies, and others. It supplies its products to medical institutions, including hospitals, clinics, dispensing pharmacies, etc. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was incorporated in 1947 and is headquartered in Toyama, Japan.
NHKFF Financial Timeline
Browse a chronological timeline of Nichi-Iko Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Feb 2023
EPS came in at -$231.90 , while revenue for the quarter reached $365.90M .
Earnings released on 14 Nov 2022
EPS came in at -$718.36 , while revenue for the quarter reached $305.60M .
Earnings released on 12 Aug 2022
EPS came in at -$59.63 , while revenue for the quarter reached $346.24M .
Earnings released on 12 May 2022
EPS came in at -$1.32K , while revenue for the quarter reached $361.21M .
Earnings released on 14 Feb 2022
EPS came in at -$11.24 , while revenue for the quarter reached $425.67M .
Earnings released on 12 Nov 2021
EPS came in at -$164.47 , while revenue for the quarter reached $385.92M .
Earnings released on 10 Aug 2021
EPS came in at -$58.88 , while revenue for the quarter reached $386.39M .
Earnings released on 14 May 2021
EPS came in at -$61.82 , while revenue for the quarter reached $446.67M .
Earnings released on 10 Feb 2021
EPS came in at -$5.66 , while revenue for the quarter reached $476.27M .
Earnings released on 11 Nov 2020
EPS came in at -$2.26 , while revenue for the quarter reached $420.28M .
Dividend declared on 18 May 2020
A dividend of $0.09 per share was announced, adjusted to $0.09. The dividend was paid on 21 Jun 2021.
Dividend declared on 18 May 2020
A dividend of $0.14 per share was announced, adjusted to $0.14. The dividend was paid on 11 Dec 2020.
NHKFF Stock Performance
Access detailed NHKFF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.